Literature DB >> 26966523

Correlation of esophageal clearance and dysphagia symptom assessment after treatment for achalasia.

Claudia Krieger-Grübel1, Radu Tutuian2, Jan Borovicka1.   

Abstract

BACKGROUND: Early relapse after treatment of achalasia occurs in 10-32 % of patients. The best method to follow up these patients is not known. Symptoms often do not correlate with esophageal clearance: some patients are oligosymptomatic despite persistent esophageal stasis/dilatation. AIM: The aim was to compare two methods of measurement of esophageal clearance (impedance manometry with barium swallow) in achalasia patients following treatment. Symptom assessment (Eckardt score/detailed dysphagia questions) was correlated with objective measurements of esophageal stasis (barium swallow and impedance manometry) in achalasia patients following treatment.
METHODS: Post-treatment patients were followed up after median 38.4 months (median range 1-144 months). Symptoms were quantified using the Eckardt score and detailed dysphagia questions. Timed barium swallow quantified distal esophageal retention 0.5, 1, 3, and 5 minutes after oral contrast and impedance manometry assessed total and segmental esophageal clearance during water/viscous swallows and free drinking (200 mL).
RESULTS: Thirty-two patients (7 women, age 48.3; range 20-74) completed all investigations. Bolus retention in the distal esophagus assessed by impedance correlated well with barium swallow. There were no differences in impedance and timed barium swallow parameters between patients with Eckardt score 0-2 points or ≥3 points. Nine (28%) patients had an Eckardt score ≥3 points and 21 (66%) had ≥1 point in the detailed dysphagia questions. Patients without any dysphagia history had lower barium column height and width at 3 and 5 minutes compared to those with ≥1 positive answer in the detailed dysphagia questions. Correlation between the Eckardt score and detailed dysphagia questions was moderately good (r = 0.546; p = 0.001).
CONCLUSION: A detailed history of esophageal dysphagia rather than the Eckardt score is more sensitive to detect oligosymptomatic patients with disturbed esophageal clearance. Impedance manometry correlates well with the timed-barium swallow examination and represents an alternative objective assessment as it avoids radiation exposure.

Entities:  

Keywords:  Achalasia; impedance manometry; questionnaire; symptom assessment; timed barium swallow

Year:  2015        PMID: 26966523      PMCID: PMC4766546          DOI: 10.1177/2050640615584732

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  14 in total

1.  The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia.

Authors:  Marcelo F Vela; Joel E Richter; Farah Khandwala; Eugene H Blackstone; Don Wachsberger; Mark E Baker; Thomas W Rice
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05       Impact factor: 11.382

2.  Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia.

Authors:  Frank Zerbib; Valérie Thétiot; Frédérique Richy; Dafr-Allah Benajah; Laurent Message; Hervé Lamouliatte
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

3.  Impedance nadir values correlate with barium bolus amount.

Authors:  H Imam; F Marrero; S Shay
Journal:  Dis Esophagus       Date:  2012-01-13       Impact factor: 3.429

4.  Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia.

Authors:  Guy E Boeckxstaens; Vito Annese; Stanislas Bruley des Varannes; Stanislas Chaussade; Mario Costantini; Antonello Cuttitta; J Ignasi Elizalde; Uberto Fumagalli; Marianne Gaudric; Wout O Rohof; André J Smout; Jan Tack; Aeilko H Zwinderman; Giovanni Zaninotto; Olivier R Busch
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

5.  Modern management of achalasia.

Authors:  Joel E Richter
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

6.  Bolus transit patterns in healthy subjects: a study using simultaneous impedance monitoring, videoesophagram, and esophageal manometry.

Authors:  Hala Imam; Steven Shay; Aman Ali; Mark Baker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05       Impact factor: 4.052

7.  Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment.

Authors:  M F Vaezi; M E Baker; E Achkar; J E Richter
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 8.  Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis.

Authors:  Guilherme M Campos; Eric Vittinghoff; Charlotte Rabl; Mark Takata; Michael Gadenstätter; Feng Lin; Ruxandra Ciovica
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

9.  Return of esophageal function after treatment for achalasia as determined by impedance-manometry.

Authors:  Roger P Tatum; Jamie A Wong; Edgar J Figueredo; Valeria Martin; Brant K Oelschlager
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

10.  Predictors for outcome of failure of balloon dilatation in patients with achalasia.

Authors:  J Alderliesten; J M Conchillo; I Leeuwenburgh; E W Steyerberg; E J Kuipers
Journal:  Gut       Date:  2010-11-10       Impact factor: 23.059

View more
  3 in total

Review 1.  Achalasia: It Is Not All Black and White.

Authors:  Santosh Sanagapalli; Rami Sweis
Journal:  Curr Gastroenterol Rep       Date:  2017-06

Review 2.  How to Optimally Apply Impedance in the Evaluation of Esophageal Dysmotility.

Authors:  Amit Patel; C Prakash Gyawali
Journal:  Curr Gastroenterol Rep       Date:  2016-11

3.  Improved Assessment of Bolus Clearance in Patients With Achalasia Using High-Resolution Impedance Manometry.

Authors:  Dustin A Carlson; Claire A Beveridge; Zhiyue Lin; Michelle Balla; Dyanna Gregory; Michael Tye; Katherine Ritter; Peter J Kahrilas; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-07       Impact factor: 11.382

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.